The in vivo relevance of the NLRP3 inflammasome in Alzheimer's disease has recently been demonstrated in the APP/PS1 mouse model where NLRP3-deficient mice show less severe disease symptoms [19]. Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.